Article Details

ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Investment Research

Retrieved on: 2021-02-17 20:48:45

Tags for this article:

Click the tags to see associated articles and topics

ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Investment Research. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 731,723 shares of the biotechnology company's stock valued at $1,748,000 after buying an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up